APA (7th ed.) Citation

C, N., M, K. N., JC, H., DB, U. K., V, S., R, M., . . . K, M. (2023). β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy. Frontiers in immunology, 14, 1204907. https://doi.org/10.3389/fimmu.2023.1204907

Chicago Style (17th ed.) Citation

C, Nakagawa, et al. "β-CATENIN Stabilizes HIF2 Through LncRNA and Inhibits Intravenous Immunoglobulin Immunotherapy." Frontiers in Immunology 14 (2023): 1204907. https://doi.org/10.3389/fimmu.2023.1204907.

MLA (9th ed.) Citation

C, Nakagawa, et al. "β-CATENIN Stabilizes HIF2 Through LncRNA and Inhibits Intravenous Immunoglobulin Immunotherapy." Frontiers in Immunology, vol. 14, 2023, p. 1204907, https://doi.org/10.3389/fimmu.2023.1204907.